the outcome of frozen embryo transfer
Conditions
Interventions
the vaccination group: SARS-CoV-2 inactivated vaccine
Non-vaccination group:No inactivated SARS-CoV-2 vaccine was given
One dose group:One dose of SARS-CoV-2 inactivated vaccine was administered
Two doses group:Two doses of SARS-CoV-2 inactivated vaccine was administered
Three doses group:Three doses of SARS-CoV-2 inactivated vaccine was administered
= 1 month group:The interval between the last dose of SARS-CoV-2 inactivated vaccine and FET was = 1 month
1–2 months group:The interval between the last dose of SARS-CoV-2 inactivated vaccine and FET was 1-2 months
=2 months group:The interval between the last dose of SARS-CoV-2 inactivated vaccine and FET was =2 months
Sponsors
The Children'sHospital of Shanxi and Women Health Center of Shanxi
Eligibility
Sex/Gender
Female
Age
29 Years to 35 Years
Inclusion criteria
Inclusion criteria: the age was 20-40 years old; the menstrual cycle was regular (24-35 days); the morphology of the uterine cavity was normal; there were transferrable frozen embryos or blastulas.
Exclusion criteria
Exclusion criteria: one or both spouses had chromosome abnormalities; the uterine was malformed; there was a history of endometrial tuberculosis; patients had adenomyosis or fibroid pressing on the uterine cavity; there were repeated uterine dropsy; endometrial polyp; obvious hydrosalpinx; the thickness of endometrium was less than 8 mm; repeated implantation failure (embryo transfer and implantation failed for = 3 times).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the clinical pregnancy rate; the first trimester abortion rate;the biochemical pregnancy rate;the premature birth rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| the ectopic pregnancy rate;the implantation rate ;thelive birth rate;the neonatal weight; | — |
Countries
China
Contacts
Public ContactZhang Xueluo
The Children'sHospital of Shanxi and Women Health Center of Shanxi
Outcome results
None listed